ロード中...
Exenatide Once-Weekly Clinical Development: Safety and Efficacy Across a Range of Background Therapies
In patients with type 2 diabetes mellitus (T2DM), the physiologic glucagon-like peptide-1 (GLP-1) response, which is involved in glucose regulation through several mechanisms, is dysfunctional. GLP-1 receptor agonists can fill an unmet therapeutic need in the treatment of T2DM: improving glycemic co...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3303092/ https://ncbi.nlm.nih.gov/pubmed/21732798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2011.0076 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|